Cite
APA Citation
An, I. B., Byun, M. S., Yang, S. I., Choi, Y., Woo, J. W., Jang, H. C., & Sung, Y. C. (2020). a glycosylated Fc‐fused glucagon‐like peptide‐1 receptor agonist exhibits equivalent glucose lowering to but fewer gastrointestinal side effects than dulaglutide. Diabetes, obesity & metabolism, 22(8), 1455–1468. http://access.bl.uk/ark:/81055/vdc_100103803529.0x000029